Skip to main content
Log in

Effects of a single high oral dose of thyroxine on the pituitary-thyroid-axis

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Ten euthyroid and 9 hypothyroid volunteers were orally administered 2 mg L-thyroxine (T4) to study the interaction between substitutive and suppressive effects of a single high T4 dose. After a significant rise in the serum T4 concentration for 5 days in euthyroid and for 11 days in hypothyroid patients an inhibition of basal and of TRH stimulated TSH release was observed. Maximal inhibition of the TSH response in hypothyroid patients occurred 1 to 7 days after the individual T4 peak. This interval was significantly correlated to the extent of the respective T4 rise. In euthyroid subjects TSH response was significantly inhibited for 8, in hypothyroid patients for 22 days. In all but 3 of the euthyroid patients there was a significant inhibition of the thyroidal 132I uptake on day 8. Normalization of thyroidal 132I uptake and of pituitary TSH secretion generally coincided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wallack W.S., Adelberg H.M, Nicoloff J.T. A thyroid suppression test using a single dose of L-thyroxine. N. Engl. J. Med. 283: 401, 1970.

    Article  Google Scholar 

  2. Bernstein R.S., Robbins J. Intermittent therapy with L-thyroxine. N. Engl. J. Med. 281: 26,1969.

    Article  Google Scholar 

  3. Sekadde C.B., Slaunwhite jr. W.R., Aceto jr. T., Murray K. Administration of thyroxine once a week. J. Clin. Endocrinol. Metab. 39: 759, 1974.

    Article  CAS  PubMed  Google Scholar 

  4. Holvey D.N., Goodner C.J., Nicoloff J.T., Dowling J.T. Treatment of myxedema coma with intravenous thyroxine. Arch. Intern. Med. 113: 139, 1964.

    Article  Google Scholar 

  5. Ridgeway E.C., McCammon J.A., Benotti J., Maloof F. Metabolic responses in myxedema to large doses of intravenous L-thyroxine. Ann. Intern. Med. 77: 549, 1972.

    Article  Google Scholar 

  6. Alexander W.D., McG Harden R., Shimmins J. Thyroidal suppressibility by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs. Lancet 2: 1041, 1966.

    Article  CAS  PubMed  Google Scholar 

  7. Vice P.A., Clarck F., Schardt W., Evered D. Studies on the control of thyrotropin secretion in normal man. Clin. Endocrinol. (Oxf.) 5: 515, 1976.

    Article  CAS  Google Scholar 

  8. Wenzel K.W., Meinhold H., Schleusener H. Different effects of oral doses of triiodothyronine of thyroxine on the inhibition of thyrotropin releasing hormone (TSH) mediated thyrotropin (TSH) response in man. Acta Endocrinol. (Kbh.) 80: 42, 1975.

    CAS  Google Scholar 

  9. Ljundgren J.G., Persson B. Subcutaneous administration of sodium L-thyroxine to patients with hypothyroidism. Acta Med. Scand. 197: 471, 1975.

    Article  Google Scholar 

  10. Wenzel K.W. Einmal wöchentliche intravenöse L-Thyroxin-Substitution bei Hypothyreose. Schweiz. Med. Wochenschn. 108: 416, 1978.

    CAS  Google Scholar 

  11. Bowers C.Y., Lee K.L., Schally A.V. A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: Effects of puromycin and cyclohexemide. Endocrinology 82: 75, 1968.

    Article  CAS  PubMed  Google Scholar 

  12. Vale W., Burgus R., Guillemin R. On the mechanism of action of TRF: Effects of cyclohexemide and actinomycin on the release of TSH stimulated in vitro by TRF and its inhibition by thyroxine. Neuroendocrinology 3: 34, 1968.

    Article  CAS  Google Scholar 

  13. Crispell K.R., Parson W., Hollifield G. A study on the rate of protein synthesis before and during the administration of L-triiodothyronine to patients with myxedema and healthy volunteers using N-15 glycine. J. Clin. Invest. 35: 164, 1956.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Cotton G.E., Gorman C.A., Mayberry W.E. Suppression of thyrotropin (h-TSH) in serum of patients with myxedema of varying etiology treated with thyroid hormones. N. Engl. J. Med. 285: 529, 1971.

    Article  CAS  PubMed  Google Scholar 

  15. Vagenakis A.G., Braverman L.E., Azizi F., Portnay G.I., Ingbar S.H. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N. Engl. J. Med. 293: 681, 1975.

    Article  CAS  PubMed  Google Scholar 

  16. Hüfner M., Grujöendorfer M., Wahl R., Röher H.-D. Das Verhalten der thyreotropen Hypophysenfunktion bei Strumapatienten nach Absetzen einer Langzeitsup-pression mit Schilddrüsenhormonen. Klin. Wochenschr. 54: 535, 1976.

    Article  PubMed  Google Scholar 

  17. Wolff J. Transport of Iodine and other anions in the thyroid gland. Physiol. Rev. 44: 45, 1964.

    CAS  PubMed  Google Scholar 

  18. Dumont J.E. The action of thyrotropin on thyroid metabolism. Vitam. Horm. 29: 287, 1971.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoff, H.G., Hackenberg, K. & Reinwein, D. Effects of a single high oral dose of thyroxine on the pituitary-thyroid-axis. J Endocrinol Invest 4, 45–48 (1981). https://doi.org/10.1007/BF03349413

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349413

Key-words

Navigation